Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orlistat and acarbose for weight control in adults with obesity
IRCT20090317001774N9Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Mar 2018
- Modality
- Small Molecules, Microbiome-Derived Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of orlistat and acarbose in obesity (3 arms), sponsored by Kerman University of Medical Sciences. Primary endpoints: Age, Sex and 12 more. Started Mar 2018; status: completed.
02
Drugs
orlistatacarbose
03
Conditions
obesity
Beyond the preview
Go deeper on IRCT20090317001774N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090317001774N9.